Concourse Financial Group Securities’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-7
| Closed | -$999 | – | 883 |
|
2024
Q4 | $999 | Hold |
7
| – | – | ﹤0.01% | 2099 |
|
2024
Q3 | $1.36K | Sell |
7
-15
| -68% | -$2.91K | ﹤0.01% | 2029 |
|
2024
Q2 | $5.1K | Sell |
22
-3
| -12% | -$695 | ﹤0.01% | 1864 |
|
2024
Q1 | $5.39K | Sell |
25
-41
| -62% | -$8.84K | ﹤0.01% | 1861 |
|
2023
Q4 | $17.1K | Sell |
66
-6
| -8% | -$1.55K | ﹤0.01% | 1533 |
|
2023
Q3 | $18.5K | Buy |
72
+42
| +140% | +$10.8K | ﹤0.01% | 1461 |
|
2023
Q2 | $8.55K | Buy |
30
+3
| +11% | +$854 | ﹤0.01% | 1696 |
|
2023
Q1 | $7.51K | Buy |
27
+5
| +23% | +$1.39K | ﹤0.01% | 1743 |
|
2022
Q4 | $6.09K | Buy |
22
+7
| +47% | +$1.94K | ﹤0.01% | 1799 |
|
2022
Q3 | $4K | Hold |
15
| – | – | ﹤0.01% | 1662 |
|
2022
Q2 | $3K | Hold |
15
| – | – | ﹤0.01% | 1942 |
|
2022
Q1 | $3K | Sell |
15
-57
| -79% | -$11.4K | ﹤0.01% | 1939 |
|
2021
Q4 | $17K | Sell |
72
-100
| -58% | -$23.6K | ﹤0.01% | 1690 |
|
2021
Q3 | $49K | Buy |
172
+100
| +139% | +$28.5K | ﹤0.01% | 1312 |
|
2021
Q2 | $25K | Sell |
72
-124
| -63% | -$43.1K | ﹤0.01% | 1564 |
|
2021
Q1 | $55K | Buy |
196
+51
| +35% | +$14.3K | ﹤0.01% | 1183 |
|
2020
Q4 | $36K | Sell |
145
-2
| -1% | -$497 | ﹤0.01% | 1240 |
|
2020
Q3 | $42K | Sell |
147
-117
| -44% | -$33.4K | ﹤0.01% | 1120 |
|
2020
Q2 | $71K | Sell |
264
-21
| -7% | -$5.65K | 0.01% | 839 |
|
2020
Q1 | $90K | Sell |
285
-24
| -8% | -$7.58K | 0.01% | 694 |
|
2019
Q4 | $92K | Buy |
309
+118
| +62% | +$35.1K | 0.01% | 736 |
|
2019
Q3 | $44K | Sell |
191
-331
| -63% | -$76.3K | 0.01% | 661 |
|
2019
Q2 | $122K | Buy |
522
+270
| +107% | +$63.1K | 0.01% | 611 |
|
2019
Q1 | $59K | Buy |
252
+109
| +76% | +$25.5K | 0.01% | 817 |
|
2018
Q4 | $43K | Buy |
143
+45
| +46% | +$13.5K | 0.01% | 861 |
|
2018
Q3 | $35K | Buy |
+98
| New | +$35K | 0.01% | 669 |
|